JOHN HUBER: Open Payments
NPI 1649521758 · MORGANTOWN, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,133 in 112 payments from 21 companies in 2025. Trend: 2023 $2,514 · 2024 $2,776 · 2025 $2,133
Food & beverage: $2,133
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 41 | $618 |
| Novo Nordisk Inc | 10 | $218 |
| AstraZeneca Pharmaceuticals LP | 7 | $215 |
| PFIZER INC. | 10 | $174 |
| Phathom Pharmaceuticals, Inc. | 7 | $137 |
| Regeneron Healthcare Solutions, Inc. | 1 | $122 |
| Lilly USA, LLC | 7 | $115 |
| Astellas Pharma US Inc | 6 | $112 |
| Azurity Pharmaceuticals, Inc. | 3 | $62 |
| GlaxoSmithKline, LLC. | 3 | $46 |
Products named: VRAYLAR, QULIPTA, UBRELVY, VOQUEZNA, FARXIGA, Rybelsus, NURTEC ODT, Veozah.
Industry payments across WV — which companies pay providers there.
